VALIDATION OF K-RAS MUTATION AND TELOMERASE ACTIVITY AS BIOMARKERS IN EARLY DETECTION OF LUNG CANCER
Nevine M. Mohamed Abdel-Fattah;
Abstract
Over the next 25 years, there will be a dramatic increase in the number of people developing cancer. Globally, 10 million new cancer patients are detected each year and this will be 20 million by year 2020. Lung cancer accounts for 1 million cases in the
Other data
| Title | VALIDATION OF K-RAS MUTATION AND TELOMERASE ACTIVITY AS BIOMARKERS IN EARLY DETECTION OF LUNG CANCER | Authors | Nevine M. Mohamed Abdel-Fattah | Keywords | VALIDATION OF K-RAS MUTATION AND TELOMERASE ACTIVITY AS BIOMARKERS IN EARLY DETECTION OF LUNG CANCER | Issue Date | 2004 | Description | Over the next 25 years, there will be a dramatic increase in the number of people developing cancer. Globally, 10 million new cancer patients are detected each year and this will be 20 million by year 2020. Lung cancer accounts for 1 million cases in the |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.